Bitmine (BMNR) shares fell 4.1% to close at $19.06 after an initial rise lost momentum, despite the company holding a massive $12.6 billion in digital assets including 5.28 million Ethereum tokens. The firm recently upgraded its listing from NYSE American to the New York Stock Exchange, maintaining its BMNR ticker. Bitmine's Ethereum holdings represent 4.37% of total ETH supply, with over 89% staked via its MAVAN staking network, generating significant annualized income. The company is nearing its goal to own 5% of Ethereum's circulating supply, highlighting its strategic focus on crypto asset accumulation and staking revenue.
SharonAI Holdings reported a first-quarter EPS loss of $1.43, slightly worse than last year's $1.34 loss, with revenue declining to $294,014 from $325,092. Despite this, the company highlighted strong demand for its AI cloud services and announced an...
ImmunityBio secured exclusive U.S. development and supply rights for the Tokyo-172 strain of BCG, an investigational bladder cancer therapy not yet FDA-approved. This follows positive Phase 3 trial results showing Tokyo-172 BCG is as effective as the...
LanzaTech announced a registered direct offering of common stock to raise about $20 million, aiming to improve its financial position. Despite a 66% stock drop over the past year and a first-quarter loss of $1.77 per share, the company is making oper...
Baidu reported strong Q1 2026 earnings, with EPS of $1.75 surpassing analyst expectations of $1.67 and revenue of $4.65 billion beating estimates of $4.54 billion. The company's rapid growth in AI-powered cloud services now accounts for over half of ...
Arbor Biotechnologies appointed Mathew Pletcher, Ph.D., as its new Chief Scientific Officer, succeeding John Murphy who is retiring. Dr. Pletcher brings nearly 20 years of experience in gene therapy and rare diseases, having held leadership roles at ...
